These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19947830)

  • 41. PEPFAR Funding Associated With An Increase In Employment Among Males in Ten Sub-Saharan African Countries.
    Wagner Z; Barofsky J; Sood N
    Health Aff (Millwood); 2015 Jun; 34(6):946-53. PubMed ID: 26056199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Countries where HIV is concentrated among most-at-risk populations get disproportionally lower funding from PEPFAR.
    Grosso AL; Tram KH; Ryan O; Baral S
    Health Aff (Millwood); 2012 Jul; 31(7):1519-28. PubMed ID: 22778341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PEPFAR Investments In Governance And Health Systems Were One-Fifth Of Countries' Budgeted Funds, 2004-14.
    Moucheraud C; Sparkes S; Nakamura Y; Gage A; Atun R; Bossert TJ
    Health Aff (Millwood); 2016 May; 35(5):847-55. PubMed ID: 27140991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Think global, act local: the experience of Global Fund and PEPFAR joint cascade assessments to harmonize and strengthen key population HIV programmes in eight countries.
    Lillie TA; Baer J; Adams D; Zhao J; Wolf RC
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25125. PubMed ID: 30033537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Palliative care and support for persons with HIV/AIDS in 7 African countries: implementation experience and future priorities.
    Alexander CS; Memiah P; Henley YB; Kaiza-Kangalawe A; Shumbusho AJ; Obiefune M; Enejoh V; Stanis-Ezeobi W; Eze C; Odion E; Akpenna D; Effiong A; Miriti K; Aduda S; Oko J; Melaku GD; Baribwira C; Umutesi H; Shimabale M; Mugisa E; Amoroso A
    Am J Hosp Palliat Care; 2012 Jun; 29(4):279-85. PubMed ID: 21998442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Saving lives for a lifetime: supporting orphans and vulnerable children impacted by HIV/AIDS.
    Nyberg BJ; Yates DD; Lovich R; Coulibaly-Traore D; Sherr L; Thurman TR; Sampson A; Howard B
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S127-35. PubMed ID: 22797734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expansion of HIV Preexposure Prophylaxis to 35 PEPFAR-Supported Early Program Adopters, October 2016-September 2018.
    Djomand G; Bingham T; Benech I; Muthui M; Savva H; Alamo S; Manopaiboon C; Wheeler T; Mital S
    MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(8):212-215. PubMed ID: 32107367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The way forward: maximizing our impact through shared responsibility and smart investments.
    Goosby E
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 2():S44-7. PubMed ID: 22772391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PEPFAR Funding and Reduction in HIV Infection Rates in 12 Focus Sub-Saharan African Countries: A Quantitative Analysis.
    Chin RJ; Sangmanee D; Piergallini L
    Int J MCH AIDS; 2015; 3(2):150-8. PubMed ID: 27621994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lessons learned from a decade of partnership between PEPFAR and the Global Fund: a case study from Tanzania.
    Bilimoria NF
    Health Aff (Millwood); 2012 Jul; 31(7):1415-21. PubMed ID: 22778330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Four principles for expanding PEPFAR's role as a vital force in US health diplomacy abroad.
    Collins C; Isbell M; Sohn A; Klindera K
    Health Aff (Millwood); 2012 Jul; 31(7):1578-84. PubMed ID: 22778348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How PEPFAR's public-private partnerships achieved ambitious goals, from improving labs to strengthening supply chains.
    Sturchio JL; Cohen GM
    Health Aff (Millwood); 2012 Jul; 31(7):1450-8. PubMed ID: 22778334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PEPFAR Transitions to Country Ownership: Review of Past Donor Transitions and Application of Lessons Learned to the Eastern Caribbean.
    Vogus A; Graff K
    Glob Health Sci Pract; 2015 Jun; 3(2):274-86. PubMed ID: 26085023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tuberculosis Preventive Treatment Scale-Up Among Antiretroviral Therapy Patients - 16 Countries Supported by the U.S. President's Emergency Plan for AIDS Relief, 2017-2019.
    Melgar M; Nichols C; Cavanaugh JS; Kirking HL; Surie D; Date A; Ahmedov S; Maloney S; Fukunaga R; ;
    MMWR Morb Mortal Wkly Rep; 2020 Mar; 69(12):329-334. PubMed ID: 32214084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PEPFAR's past and future efforts to cut costs, improve efficiency, and increase the impact of global HIV programs.
    Holmes CB; Blandford JM; Sangrujee N; Stewart SR; DuBois A; Smith TR; Martin JC; Gavaghan A; Ryan CA; Goosby EP
    Health Aff (Millwood); 2012 Jul; 31(7):1553-60. PubMed ID: 22778345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. From emergency to sustainability: shifting objectives in the US Government's HIV response in Tanzania.
    Marten MG
    Glob Public Health; 2017 Aug; 12(8):988-1003. PubMed ID: 26609563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating the President's Emergency Plan for AIDS Relief: time to scale it up.
    Gross R; Bisson G
    Ann Intern Med; 2009 May; 150(10):727-8. PubMed ID: 19451581
    [No Abstract]   [Full Text] [Related]  

  • 58. Progress in voluntary medical male circumcision for HIV prevention supported by the US President's Emergency Plan for AIDS Relief through 2017: longitudinal and recent cross-sectional programme data.
    Davis SM; Hines JZ; Habel M; Grund JM; Ridzon R; Baack B; Davitte J; Thomas A; Kiggundu V; Bock N; Pordell P; Cooney C; Zaidi I; Toledo C
    BMJ Open; 2018 Sep; 8(8):e021835. PubMed ID: 30173159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-homosexual legislation and HIV-related stigma in African nations: what has been the role of PEPFAR?
    Hagopian A; Rao D; Katz A; Sanford S; Barnhart S
    Glob Health Action; 2017; 10(1):1306391. PubMed ID: 28580879
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.